Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women.

Massad LS, Evans CT, Minkoff H, Watts DH, Greenblatt RM, Levine AM, Anastos K, Young M, Seifer DB, Golub E, Cohen M.

J Womens Health (Larchmt). 2006 Jun;15(5):591-8.

PMID:
16796486
2.

Effect of HIV-1 infection and increasing immunosuppression on menstrual function.

Ezechi OC, Jogo A, Gab-Okafor C, Onwujekwe DI, Ezeobi PM, Gbajabiamila T, Adu RA, Audu RA, Musa AZ, Salu OB, Meschack E, Herbertson E, Odunukwe N, Idigbe OE.

J Obstet Gynaecol Res. 2010 Oct;36(5):1053-8.

PMID:
21058440
3.

Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.

Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, Wilson TE, Young MA, Gange SJ.

Clin Infect Dis. 2004 Sep 1;39(5):717-24.

4.

Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.

Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR.

J Infect Dis. 2004 Sep 15;190(6):1046-54.

5.

Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS).

Anastos K, Kalish LA, Palacio H, Benson CA, Delapenha R, Chirgwin K, Stonis L, Telzak EE.

J Acquir Immune Defic Syndr. 1999 Jun 1;21(2):141-7.

PMID:
10360806
6.

Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome.

Chirgwin KD, Feldman J, Muneyyirci-Delale O, Landesman S, Minkoff H.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 15;12(5):489-94.

PMID:
8757426
7.

Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.

Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, Watts H, Miotti P, Anastos K, Moxley M, Muderspach LI, Melnick S.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):432-42.

PMID:
11511819
8.

Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).

Solomon L, Stein M, Flynn C, Schuman P, Schoenbaum E, Moore J, Holmberg S, Graham NM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):253-61.

PMID:
9495226
9.

Contraceptive use among U.S. women with HIV.

Massad LS, Evans CT, Wilson TE, Golub ET, Sanchez-Keeland L, Minkoff H, Weber K, Watts DH.

J Womens Health (Larchmt). 2007 Jun;16(5):657-66.

PMID:
17627401
10.

Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.

Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ.

J Natl Cancer Inst. 2004 Jul 21;96(14):1070-6.

11.

Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV.

Massad LS, Springer G, Jacobson L, Watts H, Anastos K, Korn A, Cejtin H, Stek A, Young M, Schmidt J, Minkoff H.

AIDS. 2004 Jan 23;18(2):281-6.

PMID:
15075546
12.

The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women.

Minkoff H, Zhong Y, Strickler HD, Watts DH, Palefsky JM, Levine AM, D'Souza G, Howard AA, Plankey M, Massad LS, Burk R.

Infect Dis Obstet Gynecol. 2008;2008:587082. doi: 10.1155/2008/587082.

13.

A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants.

Navazesh M, Mulligan R, Barrón Y, Redford M, Greenspan D, Alves M, Phelan J; Women's Interagency HIV Study participants..

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jun;95(6):693-8.

PMID:
12789150
14.

Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus.

Macías J, Pineda JA, Lozano F, Corzo JE, Ramos A, León E, García-García JA, Fernández-Rivera J, Mira JA, Gómez-Mateos J.

Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):675-80.

PMID:
14574616
15.

Hormonal levels among HIV-1-seropositive women compared with high-risk HIV-seronegative women during the menstrual cycle. Women's Health Study (WHS) 001 and WHS 001a Study Team.

Cu-Uvin S, Wright DJ, Anderson D, Kovacs A, Watts DH, Cohn J, Landay A, Reichelderfer PS.

J Womens Health Gend Based Med. 2000 Oct;9(8):857-63.

PMID:
11074951
16.

The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women.

Maurer T, Rodrigues LK, Ameli N, Phanuphak N, Gange SJ, DeHovitz J, French AL, Glesby M, Jordan C, Khalsa A, Hessol NA.

Clin Infect Dis. 2004 Feb 15;38(4):579-84.

17.

The influence of stress on the menstrual cycle among newly incarcerated women.

Allsworth JE, Clarke J, Peipert JF, Hebert MR, Cooper A, Boardman LA.

Womens Health Issues. 2007 Jul-Aug;17(4):202-9.

18.

Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.

Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Di Pietro M, Migliorino G, Ouiros-Roldan E, Ladisa N, Sighinolfi L, Costarelli S, Carosi G; Italian MASTER Cohort..

Antivir Ther. 2007;12(6):941-7.

PMID:
17926648
19.

Stability of cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiology Research Study Group.

Klein RS, Sobel J, Flanigan T, Smith D, Margolick JB.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Mar 1;20(3):238-44.

PMID:
10077171
20.

Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART.

Adler DH, Kakinami L, Modisenyane T, Tshabangu N, Mohapi L, De Bruyn G, Martinson NA, Omar T.

AIDS. 2012 Aug 24;26(13):1645-52.

Items per page

Supplemental Content

Support Center